Report updates recommendations for health workers exposed to HIV.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control*; D006282:Health Personnel; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D019888:Nelfinavir / Q000627:therapeutic use; D016273:Occupational Exposure / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D014481:United States; D014492:United States Public Health Service; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D019888:Nelfinavir